Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,000
Closed -$63.3K 951
2024
Q2
$63.3K Buy
+5,000
New +$50.3K ﹤0.01% 782
2023
Q3
Sell
-10,100
Closed -$75K 896
2023
Q2
$75K Buy
+10,100
New +$79.4K ﹤0.01% 759
2023
Q1
Sell
-65,400
Closed -$672K 844
2022
Q4
$672K Buy
65,400
+30,500
+87% +$538K 0.04% 328
2022
Q3
$635K Sell
34,900
-7,700
-18% -$334K 0.03% 459
2022
Q2
$2.19M Sell
42,600
-16,900
-28% -$875K 0.09% 274
2022
Q1
$4.38M Buy
59,500
+57,000
+2,280% +$5.08M 0.16% 117
2021
Q4
$358K Sell
2,500
-7,900
-76% -$1.36M 0.01% 761
2021
Q3
$2.16M Sell
10,400
-14,900
-59% -$3.28M 0.09% 231
2021
Q2
$5.37M Sell
25,300
-20,800
-45% -$3.81M 0.22% 92
2021
Q1
$8.36M Buy
46,100
+27,500
+148% +$5.48M 0.34% 44
2020
Q4
$2.08M Buy
18,600
+15,100
+431% +$1.6M 0.08% 189
2020
Q3
$379K Sell
3,500
-6,500
-65% -$792K 0.02% 466
2020
Q2
$834K Buy
+10,000
New +$382K 0.05% 303

Other funds holding NVAX

CSS LLC's NVAX Position: Q3 2024 in Review

CSS LLC sold out of Novavax (NVAX) in Q3 2024, closing a stake of 6,000 shares — an estimated $77.5K sold.

CSS LLC first reported a position in NVAX in Q2 2020 and held it in 9 quarters. The position peaked at $1.62M in Q4 2020. 238 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • CSS LLC reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
  • CSS LLC sold 6,000 Novavax shares in Q3 2024, an estimated $77.5K.
  • CSS LLC first reported a position in Novavax in Q2 2020 and held it in 9 quarters.
  • CSS LLC's Novavax position peaked at $1.62M in Q4 2020.
  • 238 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on CSS LLC's 13F filing for Q3 2024, filed 14 Nov 2024.